Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Closed Loop with Pramlintide

A closed-loop automated insulin management system (Adaptive Insulin Meal Supervisor- AIMS) for meals utilizing continuous glucose monitoring (CGM)and subcutaneous insulin pump and a standard pramlintide therapy will be compared to a standard pramlintide therapy alone to control glucose levels in individuals with type 1 diabetes. DiAs is controlled by the subject, with assistance from the study personnel as needed.

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

collaborator

Tandem Diabetes Care, Inc.

INDUSTRY

lead

University of Virginia

OTHER

NCT01839370 - Phase 2 Study of Adaptive Insulin Meal Supervisor (AIMS) in Adults With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter